• OPEN AN ACCOUNT
Indian Indices
Nifty
24,946.50 227.90
(0.92%)
Sensex
81,615.44 -180.71
( -0.22%)
Bank Nifty
55,944.90 417.55
( 0.75%)
Nifty IT
39,073.05 603.80
( 1.57%)
Global Indices
Nasdaq
42,540.48 321.68
(0.76%)
Dow Jones
6,054.14 56.17
(0.94%)
Hang Seng
38,275.58 441.33
(1.17%)
Nikkei 225
8,875.22 24.59
(0.28%)
Forex
USD-INR
85.72 0.17
(0.19%)
EUR-INR
98.97 0.08
(0.08%)
GBP-INR
116.32 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Sameera Agro and Infra Ltd
Industry :  Food - Processing - Indian
BSE Code
ISIN Demat
Book Value()
91892
INE0PZA01015
20.2404406
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SAIFL
9.75
138.75
EPS(TTM)
Face Value()
Div & Yield %
2.39
10
0
 

Aurobindo Pharma’s US arm incorporates Cresedemo Pharma
Jun 16,2025
The purpose of incorporating this new entity is to expand the company’s pharmaceutical products business in USA.

The company has subscribed to a share capital of $10,000 divided into 10,000 shares with a nominal value of $1 each.

Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company’s consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

The scrip declined 0.38% to end at Rs 1,150.65 on the BSE.